New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various ...
VENLO, The Netherlands, March 03, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for ...
QuantiFERON-EBV RUO to help researchers understand Epstein-Barr virus (EBV) infections and related malignancies, offering a dynamic view of the host immune response // Advancing research in oncology ...
QIAGEN QGEN recently unveiled its latest offering, the QuantiFERON-EBV RUO (Research Use Only) assay. This addition to the company’s existing QuantiFERON portfolio of tests marks a significant step ...
QuantiFERON franchise benefits from new applications, products and automation options, building on strengths in tuberculosis detection while addressing new disease targets QuantiFERON SARS-CoV-2 assay ...
Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class C Certification marks milestone in QIAGEN’s transition to full compliance with new EU regulations ...
Venlo, the Netherlands, June 15, 2023 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) welcomes the publication of a new, systematic review highlighting the unique value ...
QIAGEN's New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
World Health Organization (WHO) endorses QFT-Plus as alternative IGRA test for diagnosis of TB infection, recommends new QIAreach QFT for research use in epidemiological settings QIAGEN N.V. (NYSE: ...
QuantiFERON is one of five pillars in QIAGEN’s growth strategy. In 2021, the company launched QIAreach QFT, a battery-operated portable version developed in partnership with Ellume that is ...
Venlo, the Netherlands, Oct. 04, 2023 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay.
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
HILDEN, Germany & GERMANTOWN, Md. & SHANGHAI--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QuantiFERON tuberculosis (TB) testing solution has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results